Vivo Capital, LLC Q3 2018 Filing
Filed November 13, 2018
Portfolio Value
$992.2B
Holdings
44
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (44 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDAscendis Pharma | 2,166,832 | $153.5B | 15.48% | |
| 2 | CRNXCrinetics Pharmaceuticals Inc | 3,792,169 | $108.6B | 10.95% | |
| 3 | —Biohaven Pharmaceutical Holding Company Ltd | 2,049,545 | $77.0B | 7.76% | |
| 4 | CDXSCodexis, Inc. | 2,749,343 | $47.2B | 4.75% | |
| 5 | SVASinovac Biotech Ltd | 5,900,000 | $45.0B | 4.53% | |
| 6 | ARWRArrowhead Pharmaceuticals In | 2,328,475 | $44.6B | 4.50% | |
| 7 | AMRSEURAmyris, Inc. | 5,575,118 | $44.3B | 4.46% | |
| 8 | —Menlo Therapeutics | 4,011,236 | $39.5B | 3.98% | |
| 9 | —Kadmon Holdings (KDMN) | 10,454,545 | $34.9B | 3.52% | |
| 10 | 1T7Tricida, Inc. | 991,711 | $30.3B | 3.05% | |
| 11 | KALVKalVista Pharmaceuticals, Inc. | 1,359,149 | $30.1B | 3.03% | |
| 12 | FIXXEURHomology Medicines, Inc. | 1,159,742 | $26.5B | 2.67% | |
| 13 | MEIPUSDMEI Pharma Inc (NAS) | 5,778,106 | $24.9B | 2.51% | |
| 14 | APLSApellis Pharmaceuticals, Inc. | 1,354,554 | $24.1B | 2.43% | |
| 15 | ACRSAclaris Therapeutics | 1,647,214 | $23.9B | 2.41% | |
| 16 | CLDNEUREiger BioPharmaceuticals | 1,791,257 | $21.5B | 2.17% | |
| 17 | VRNAVerona Pharma Plc | 1,492,951 | $18.7B | 1.88% | |
| 18 | XENEXenon Pharmaceuticals Inc | 1,405,476 | $18.6B | 1.87% | |
| 19 | —Nabriva Therapeutics Plc | 6,619,190 | $17.9B | 1.80% | |
| 20 | —Acer Therapeutics Inc | 565,579 | $17.4B | 1.76% | |
| 21 | —Obseva SA | 937,147 | $16.9B | 1.70% | |
| 22 | SELBUSDSelecta Biosciences, Inc. | 761,253 | $11.8B | 1.19% | |
| 23 | GLMDGalmed Pharmaceuticals Ltd | 851,492 | $11.6B | 1.17% | |
| 24 | KALAKala Pharmaceuticals, Inc. | 1,043,020 | $10.3B | 1.04% | |
| 25 | CBAYUSDCymabay Therapeutics inc | 906,000 | $10.0B | 1.01% | |
| 26 | —Zymeworks Inc | 620,134 | $9.7B | 0.98% | |
| 27 | —Soleno Therapeutics, Inc. | 4,359,683 | $9.4B | 0.95% | |
| 28 | DCPHEURDeciphera Pharmaceuticals In | 212,648 | $8.2B | 0.83% | |
| 29 | AUPHAurinia Pharmaceuticals Inc. | 1,213,290 | $8.1B | 0.81% | |
| 30 | KNSAKiniksa Pharmaceuticals-A | 264,878 | $6.8B | 0.68% | |
| 31 | —Genocea Biosciences Inc(NMS) | 8,180,000 | $6.4B | 0.64% | |
| 32 | —Zogenix, Inc. | 105,000 | $5.2B | 0.52% | |
| 33 | ARVNArvinas Holding Co LLC | 300,000 | $5.1B | 0.51% | |
| 34 | ZLABZai Lab LTD | 231,010 | $4.5B | 0.45% | |
| 35 | —Strongbridge Biopharma plc | 918,132 | $4.5B | 0.45% | |
| 36 | —Sierra Oncology, Inc | 2,438,270 | $4.1B | 0.42% | |
| 37 | —Trevena, Inc. | 1,728,000 | $3.7B | 0.37% | |
| 38 | —BioPharmX Corporation | 16,128,515 | $3.1B | 0.31% | |
| 39 | —Foamix Pharmaceuticals Ltd. | 427,500 | $2.5B | 0.25% | |
| 40 | —Akari Therapeutics Plc | 345,850 | $885.0M | 0.09% | |
| 41 | —Agile Therapeutics, Inc. | 1,513,975 | $555.0M | 0.06% | |
| 42 | —Sunesis Pharmaceuticals, Inc. | 195,474 | $391.0M | 0.04% | |
| 43 | —GTX Inc | 105,043 | $165.0M | 0.02% | |
| 44 | —Soleno Therapeutics, Inc. | 188,772 | $23.0M | 0.00% |